CC
NEO icon

Centiva Capital’s NeoGenomics NEO Stock Holding History

Centiva Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,920
Closed -$260K – 1869
2023
Q1 		$260K Buy
+14,920
New +$213K 0.01% 1119
2019
Q4 		– Sell
-12,343
Closed -$236K – 895
2019
Q3 		$236K Buy
+12,343
New +$290K 0.01% 479

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Centiva Capital's NEO Position: Q2 2023 in Review

Centiva Capital sold out of NeoGenomics (NEO) in Q2 2023, closing a stake of 14,920 shares — an estimated $260K sold.

Centiva Capital first reported a position in NEO in Q3 2019 and held it in 2 quarters. The position peaked at $260K in Q1 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2023.

  • Centiva Capital reported no remaining NeoGenomics position as of Q2 2023 after selling out during the quarter.
  • Centiva Capital sold 14,920 NeoGenomics shares in Q2 2023, an estimated $260K.
  • Centiva Capital first reported a position in NeoGenomics in Q3 2019 and held it in 2 quarters.
  • Centiva Capital's NeoGenomics position peaked at $260K in Q1 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.

Based on Centiva Capital's 13F filing for Q2 2023, filed 14 Aug 2023.